Cell therapy and the safety of embryonic stem cell-derived grafts
- 1 January 2007
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 25 (1) , 24-32
- https://doi.org/10.1016/j.tibtech.2006.10.010
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- The Long Journey from Stem Cells to Medical ProductCell, 2006
- In Vivo Tracking of Stem Cells for Clinical Trials in Cardiovascular DiseaseCirculation, 2004
- Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-upAmerican Heart Journal, 2004
- Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiationBiotechnology & Bioengineering, 2004
- Cell therapy using human embryonic stem cellsTransplant Immunology, 2004
- Differences between human and mouse embryonic stem cellsDevelopmental Biology, 2004
- Pluripotency and tumorigenicityNature Genetics, 2002
- Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastomaBone Marrow Transplantation, 2002
- In vitro differentiation of transplantable neural precursors from human embryonic stem cellsNature Biotechnology, 2001
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998